CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,628 | -10.9% | 16,688 | -1.3% | 0.00% | – |
| Q2 2023 | $551,506 | -10.0% | 16,907 | -2.9% | 0.00% | -100.0% |
| Q1 2023 | $612,975 | -23.2% | 17,419 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $797,635 | +12.3% | 17,408 | +18.8% | 0.00% | 0.0% |
| Q3 2022 | $710,000 | +15.3% | 14,656 | -6.5% | 0.00% | 0.0% |
| Q2 2022 | $616,000 | +9.2% | 15,681 | +2.3% | 0.00% | – |
| Q1 2022 | $564,000 | +166.0% | 15,321 | +56.6% | 0.00% | – |
| Q3 2020 | $212,000 | +101.9% | 9,784 | -14.6% | 0.00% | – |
| Q3 2016 | $105,000 | -11.0% | 11,450 | -8.0% | 0.00% | – |
| Q2 2016 | $118,000 | +32.6% | 12,450 | -1.3% | 0.00% | – |
| Q1 2016 | $89,000 | – | 12,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |